Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Our faculty author, co-author and contribute to more than 1500 peer-reviewed scientific publications each year. Find their recent publications below, and filter by division.
Search the faculty directory to find an individual's list of publications.
Fulton, JJ, LeBlanc, TW, Cutson, TM, Porter Starr, KN, Kamal, A, Ramos, K, Freiermuth, CE, McDuffie, JR, Kosinski, A, Adam, S, Nagi, A, and Williams, JW. "Integrated outpatient palliative care for patients with advanced cancer: A systematic review and meta-analysis." Palliative Medicine (November 29, 2018): 269216318812633-null.
Elnair, R, and Galal, A. "Finding the right BCR-ABL1 tyrosine kinase inhibitor: a case report of successful treatment of a patient with chronic myeloid leukemia and a V299L mutation using nilotinib." Bmc Cancer 18, no. 1 (November 12, 2018): 1097-null.
Ray, EM, Riedel, RF, LeBlanc, TW, Rushing, CN, and Galanos, AN. "Assessing the Impact of a Novel Integrated Palliative Care and Medical Oncology Inpatient Service on Health Care Utilization before Hospice Enrollment." Journal of Palliative Medicine (November 3, 2018).
Carpenter, PA, Logan, BR, Lee, SJ, Weisdorf, DJ, Johnston, L, Costa, LJ, Kitko, CL, Bolaños-Meade, J, Sarantopoulos, S, Alousi, AM, Abhyankar, S, Waller, EK, Mendizabal, A, Zhu, J, O'Brien, KA, Lazaryan, A, Wu, J, Nemecek, ER, Pavletic, SZ, Cutler, CS, Horowitz, MM, Arora, M, and BMT CTN., . "A phase II/III randomized, multicenter trial of prednisone/sirolimus versus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft-versus-host disease: BMT CTN 0801." Haematologica 103, no. 11 (November 2018): 1915-1924.
Mato, AR, Roeker, LE, Allan, JN, Pagel, JM, Brander, DM, Hill, BT, Cheson, BD, Furman, RR, Lamanna, N, Tam, CS, Handunnetti, S, Jacobs, R, Lansigan, F, Bhavsar, E, Barr, PM, Shadman, M, Skarbnik, AP, Goy, A, Beach, DF, Svoboda, J, Pu, JJ, Sehgal, AR, Zent, CS, Tuncer, HH, Schuster, SJ, Pickens, PV, Shah, NN, Rhodes, J, Ujjani, CS, and Nabhan, C. "Outcomes of front-line ibrutinib treated CLL patients excluded from landmark clinical trial." American Journal of Hematology 93, no. 11 (November 2018): 1394-1401.
Jamy, O, Bae, S, Costa, LJ, Erba, HP, and Papadantonakis, N. "Outcomes of fludarabine, high dose cytarabine and granulocyte-colony stimulating factor (FLAG) as re-induction for residual acute myeloid leukemia on day 14 bone marrow." Leukemia Research 74 (November 2018): 64-67.
Stanland, LJ, and Luftig, MA. "Molecular features and translational outlook for Epstein–Barr virus-associated gastric cancer." Future Virology 13, no. 11 (November 2018): 803-818.
Radojcic, V, Paz, K, Chung, J, Du, J, Perkey, ET, Flynn, R, Ivcevic, S, Zaiken, M, Friedman, A, Yan, M, Pletneva, MA, Sarantopoulos, S, Siebel, CW, Blazar, BR, and Maillard, I. "Notch signaling mediated by Delta-like ligands 1 and 4 controls the pathogenesis of chronic GVHD in mice." Blood 132, no. 20 (November 2018): 2188-2200.
Troy, JD, Locke, SC, Samsa, GP, Feliciano, J, Richhariya, A, and LeBlanc, TW. "Patient-reported distress in Hodgkin lymphoma across the survivorship continuum." Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer (October 30, 2018).
Khera, N, Hamilton, BK, Pidala, JA, Wood, WA, Wu, V, Voutsinas, J, Onstad, L, Alousi, AM, Broady, R, Chen, GL, Arora, M, Cutler, C, Flowers, ME, Ganetsky, A, Jagasia, M, McCarthy, PL, Sarantopoulos, S, Abel, GA, Majhail, NS, and Lee, SJ. "Employment, Insurance, and Financial Experiences of Patients with Chronic Graft-versus-Host Disease in North America." October 5, 2018.